YUYavuz Uyar

Yavuz Uyar

*This is an algorithmically generated author record based on publicly available information.

Yavuz Uyar has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 July 2012
      • Vol. 46  (3) , 488-92

    [A fatal case of West Nile virus encephalitis].

    by Ayşegül Yeşilkaya, Ozlem Kurt Azap, Hande Aarslan, Dilek Yağcı Çağlayık, Yavuz Uyar, Gülay Korukluoğlu, Aykut Ozkul

    Although West Nile virus (WNV) serologic evidence has been well demonstrated throghout Turkey in the last 40 years; the first symptomatic WNV infection was reported in 2009 and increased number of cases were reported during August 2010. In that period WNV encephalitis was diagnosed serologically (WNV IgM positivity in serum sample detected by ELISA and IFA) and confirmed by plaque reduction neutralization test in a 76-year-old man who was admitted to Baskent University Faculty of Medicine with complaints of fever, impaired consciousness and generalized tremors. Despite all supportive treatment, he died on the 9th day of hospitalization. In this report, detailed clinical course, laboratory features and diagnosis of this mortal case of WNV encephalitis were described. WNV encephalitis should be considered in the differential diagnosis of patients with fever of unknown origin and loss of consciousness especially in summer and early fall in Turkey.

    • 1 January 2012
      • Vol. 46  (1) , 122-8

    [An imported Chikungunya fever case from New Delhi, India to Ankara, Turkey: the first imported case of Turkey and review of the literature].

    by Dilek Yağcı Çağlayık, Yavuz Uyar, Gülay Korukluoğlu, Mustafa Ertek, Serhat Unal

    Chikungunya virus (CHIKV) is an arthropod-borne alphavirus that causes an acute febrile illness, chikungunya fever. CHIKV virus is geographically distributed in Africa, India, and South-East Asia. Chikungunya fever outbreaks have been reported from India since 2006. The incubation period is 3-7 days, and the disease is characterized by sudden onset of high fever and severe arthralgia. Other symptoms can be rash, headache, fatigue, nausea-vomiting, and myalgias. Here, we report the first Chikungunya case imported from India, New-Delhi to Ankara, Turkey. In December 2010, a 55-year-old female Turkish government employee living in urban area of New Delhi for the last 3 years had sudden onset fever up to 38.4°C for 2 days. Itching rash and arthralgia also developed. Symptomatic treatment was given to patient in New Delhi. She returned to Turkey and was admitted to Hacettepe University Medical Faculty, Department of Internal Medicine, Infectious Diseases Unit, since arthralgia has continued on the 26th day of her complaints. Hepatomegaly and tenosynovitis were detected in her physical examination. Serum sample sent to Refik Saydam National Public Health Agency, Virology Reference and Research Laboratory, yielded negative results for specific IgM and IgG antibodies against Hantavirus and Dengue virus types 1-4; however, the results were positive for CHIKV specific IgM and IgG antibodies by commercial immunofluorescence method (Euroimmun, Germany). CHIKV RNA which was searched by in-house real-time RT-PCR was negative. The second serum sample obtained three weeks later also found positive for CHIKV specific IgM and IgG antibodies. This was the first laboratory confirmed imported Chikungunya case in Turkey. There are predictions regarding the presence of Aedes species mosquitos that can transmit this virus in Turkey. This case report will be an alarming signal for the clinicians in our country to consider Chikungunya fever in the differential diagnosis of patients presenting with fever, arthralgia and rash.


    • 1 July 2010
      • Vol. 44  (3) , 479-87

    [Hantavirus infection: two case reports from a province in the Eastern Black Sea Region, Turkey].

    by Selçuk Kaya, Gürdal Yılmaz, Sükrü Erensoy, Dilek Yağçı Çağlayık, Yavuz Uyar, Iftihar Köksal

    Hantaviruses which are the members of Bunyaviridae, differ from other members of this family since they are transmitted to humans by rodents. More than 200.000 cases of hantavirus infections are reported annually worldwide. Hantaviruses can lead to two different types of infection in humans, namely, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). HFRS is the most common type of hantavirus infection in Europe and Asia and the most common virus types are Dobrava, Puumala, Hantaan and Seoul. A total of 25 hantavirus suspected cases have been reported from the Western Black Sea region of Turkey and 12 of these were confirmed serologically as "Puumala" subtype. Serological tests such as indirect immunofluorescence assay (IFA), are used for diagnosis and typing of the hantaviruses, however, since cross-reactions are common between the subtypes, the results of these tests should be confirmed by other methods. In this report two cases with hantavirus infection defined serologically were presented. Two male patients, 55 and 50 years old, respectively, living in Giresun province of Eastern Black Sea region, Turkey, were admitted to the State Hospital with the complaints of fever, sweating and diarrhoea without blood or mucus. Since thrombocytopenia and renal failure were detected in these two cases, they were transferred to the University Hospital. Presence of fever, thrombocytopenia and renal failure, with no laboratory findings of a bacterial infection and no growth of microoorganisms in the clinical specimens, admittance of the patients during summer and history of being present in the fields, necessitated to rule out leptospirosis, Crimean Kongo hemorrhagic fever and hantavirus infection which were all endemic in our area. Further investigation of the serum samples at the National Reference Virology Laboratory by IFA (Hantavirus Mosaic-1, Euroimmun, Germany) revealed hantavirus IgM and IgG antibodies ≥ 1:100 titer and the results were confirmed by immunoblot test (Hantavirus Profile 1 EUROLINE IgG and IgM, Euroimmun, Germany). Hantavirus Dobrava subtype was determined in both of the cases. Reverse transcriptase real-time PCR (Hantavirus Renal Syndrome General-type I&II Real Time RT-PCR; Shanghai ZJ Bio-Tech, China) revealed negative result. The first case was discharged with complete cure, however, the second case died. These cases which were the first cases from the Eastern Black Sea Region emphasized that hantavirus infections should be taken into consideration in patients presenting with fever, thrombocytopenia and renal function disturbance.


    • 1 January 2010
      • Vol. 44  (1) , 57-64

    [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].

    by Yavuz Uyar, Ahmet Carhan, Nurhan Albayrak, Ayşe Başak Altaş

    Crimean-Congo hemorrhagic fever (CCHF) is a fatal zoonotic viral haemorrhagic infection described in Africa, Asia, Eastern Europe, and the Middle East. CCHF virus (CCHFV) classified in Bunyaviridae family and Nairovirus genus, is transmitted to humans by tick (Hyalomma and Ixodid) bites and human to human transmission may occur by direct contact with blood or other infected tissues. The disease became endemic and a public health problem since 2002 outbreak in Turkey. The specific laboratory diagnosis and confirmation of the disease is performed in Refik Saydam National Public Health Agency, by using molecular and serological methods. For this purpose serum and/or plasma samples from suspected CCHF patients are submitted to the reference laboratory with an official "possible case report form". According to the algorithm in our laboratory, the first samples which were sent from possible acute cases were searched initially by an in-house real time-polymerase chain reaction (PCR) method and those which were found negative with PCR, were then studied by in-house ELISA method in terms of CCHF-IgM antibodies. In 2008, a total of 4634 samples obtained from 2855 CCHF suspected patients have been examined for the positivity of CCHFV, and 1315 (46%) cases were found to be positive by molecular and/or serologic methods. The aim of this study was to evaluate the results of 726 cases whose at least 2 samples were sent to laboratory, with at least 1 positivity in at least 1 clinical sample with either PCR or IgM ELISA, or both, and with complete informations in possible case report form, during 2008 in Turkey. The positive results were also analyzed according to the starting date of the complaints and the date samples received in order to evaluate the positivity rates of molecular and serological methods with regard to the time. The first serum samples in 94.1% (683/726) of cases were found to be positive with PCR and/or ELISA-IgM methods. PCR positivity was found as 78.1% (567/726), while CCHFV-IgM positivity was detected in 116 (72.9%) in the remaining 159 PCR negative samples. In the first sera, PCR and ELISA results were evaluated in relation to the start of complaints and the date samples received. After the onset of symptoms, PCR positivity was determined as 83.4% in the samples taken in the first 5 days, and reduces to 67.5% in the samples between 6-10 days. The detection rate of CCHFV-IgM increases up to 95% when PCR positivity rate decreases after the 5th day. As expected, positivity is determined to be high by PCR in the first days, and ELISA-IgM after the 5th day. In conclusion, recording clinical data such as the onset of disease and the date of sample received ensure the accurate evaluation of the disease and the laboratory results are reliably accomplished in a short time.


    • 1 April 2009
      • Vol. 43  (2) , 235-41

    [Influenza surveillance results in 2007-2008 winter season in nine provinces of Turkey].

    by Ahmet Carhan, Ayşe Başak Altaş, Nurhan Albayrak, Yavuz Uyar

    Influenza virus infections constitute a serious public health problem owing to their epidemic and pandemic potential. Turkish Ministry of Health established the national influenza surveillance programme in two institutes to detect the virus types leading to the illness and the efficiency of the seasonal vaccine. Influenza surveillance is performed by Refik Saydam Hygiene Center, National Influenza Laboratory in nine provinces (which are located at central, northeast, south and east parts of Turkey) and by Istanbul University, Medical Faculty, Virology Laboratory in five provinces (which are located at west and northwest parts of Turkey). These two centers are the members of international information networks. The surveillance was aimed to contribute to the detection of influenza viruses with pandemic potential and also to determine the predominant strain circulating in Turkey. During November 2007-May 2008 period a total of 1157 clinical specimens collected from 90 health centers which were the representatives of nine provinces (Ankara, Samsun, Trabzon, Erzurum, Adana, Konya, Diyarbakir, Malatya and Van) were investigated for the presence of influenza virus and other respiratory viruses (Parainfluenza virus types 1-3, Respiratory Synctial Virus and Adenovirus). Samples were identified and subtyped by both molecular (real-time PCR) and cell culture techniques (MDCK and Hep-2). Influenza virus and at least one of the other respiratory viruses were detected in 321 (27.7%) and two different viruses in 16 of the specimens (total= 337). When all the specimens were considered, the most frequently identified virus was influenza A (n=188, 16.2%), H1N1 being 6.3% and H3N2 9.9%.The rate of identification for influenza B was 7.6% (n=88), for parainfluenza was 2.3% (n=27), for adenovirus was 2% (n=24) and for RSV was 0.9% (n=10). When only the positive specimens (n=337) were evaluated, influenza A was again the most frequently (55.7%) encountered virus, H1N1 being 38.8% and H3N2 61.2% of all. Influenza B was in the second rank with 26.1% frequency among the positive specimens. The results showed that influenza activity started around November and ended around May. When the distribution of influenza viruses were analysed according to months, Influenza A H1N1 predominated in January, influenza A H3N2 in December and February. influenza B viruses started to increase in February, and were also detected in May. The 2007-2008 influenza season in Turkey was characterized by moderate clinical activity, and a predominance of influenza A H3N2. These results indicate good match between the vaccine virus strains and the reported virus strains.


    • 1 October 2008
      • Vol. 42  (4) , 607-15

    [Evaluation of laboratory diagnosis of the first norovirus outbreak in Turkey in 2008].

    by Yavuz Uyar, Ahmet Carhan, Etem Ozkaya, Mustafa Ertek

    Norovirus (NoV) is one of the most prominent agents of gastroenteritis and water/food-borne outbreaks affecting all of the age groups in the world. As the identification of the etiologic agent is important during gastroenteritis outbreaks, it is recommended to combine two different methods for rapid and reliable laboratory diagnosis of NoV. Although NoV outbreaks have been observed in many different countries of the world, there was no report on "NoV outbreak" in Turkey till 2008 due to the absence of a regular surveillance system for non-bacterial gastroenteritis. This study aimed to present the laboratory results for "the first NoV outbreak" in Turkey in 2008. A number of cases with diarrhea and nausea/vomiting initially emerged in Aksaray (located at the southern part of central Anatolia) in May 2008, followed by cases from Sereflikochisar, Kirsehir, and Adana provinces (located at central and southern Anatolia; geographically closer regions). However, regional laboratories declared that no known bacterial (Salmonella spp., Shigella spp., enterotoxigenic Escherichia coli), viral (Rotavirus, Adenovirus) and parasitic agents were detected. A total of 50 stool samples were sent to the Virology Reference Laboratory (Refik Saydam Hygiene Center, Ankara) for further investigations including NoV. For the investigation of NoV, the samples were analysed by using antigen-ELISA (Ridascreen, R-Biopharm, Germany) and real-time polymerase chain reaction(PCR) (Roche Diagnostics GmbH, Germany) methods. Of the samples, 26% (13/50) were found antigen positive, whereas 33% (13/40) were positive for viral nucleic acids. The positivity rates determined by ELISA and PCR were as follows, respectively; 57% (4/7) and 71% (5/7) in Aksaray, 25% (1/4) and 25% (1/4) in Sereflikochisar, 28% (7/25) and 40% (6/15) in Kirsehir, 7% (1/14) and 7% (1/14) in Adana. Nine (69.2%), and 4 (30.8%) out of 13 positive samples were genotyped as NoV GI and GII, respectively. The sensitivity and specificity of antigen-ELISA method were found as 61.5% and 100%, respectively, when compared with real-time PCR. In conclusion, further epidemiological studies and genomic analysis are needed for the detection and control of circulating strains in Turkey, since NoV outbreaks spread rapidly and cause serious economical and workforce loss.